Exploring low haemoglobin density as a no‐added‐cost screening marker to assess iron deficiency
Vox Sanguinis · 2026
DOI: 10.1111/vox.70135 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Jesse Qiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, University of California, Irvine, Orange, California, USA. Hauptthemen laut MEDLINE: Hemoglobins, Anemia, Iron-Deficiency, Mass Screening, Iron Deficiencies. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and Objectives Iron deficiency (ID), with or without anaemia, affects over 1 billion people globally. Early detection is essential, but current diagnostic tools may be costly, logistically complex and not widely accessible. This study evaluates low haemoglobin density percentage (LHD%), derived from mean corpuscular haemoglobin concentration (MCHC) in routine complete blood counts (CBCs), as a no‐added‐cost, accessible alternative for ID screening. Materials and Methods We retrospectively analysed 3526 adult patient records (January–April 2025) from a single‐centre institution, including those with iron panel and CBC performed within 24 h. Patients were categorized as Normal, ID, ID anaemia (IDA) or anaemia without ID (AwoID). LHD% was calculated and assessed across groups using receiver operating characteristic (ROC) curve analyses for cutoff determinations.
Results
Median LHD% increased progressively from the Normal group (2.99%) to the IDA group (6.71%). ROC analysis showed modest but acceptable diagnostic performance: area under the curve (AUC) was 0.677 overall, 0.687 in non‐anaemic and 0.684 in anaemic subjects. Specific LHD% cutoffs varied by context: >4.48% for general screening (61% sensitivity, 67% specificity), >7.02% for donor screening (95% specificity) and >3.74% for anaemia workup (75% sensitivity).
Conclusion
LHD% shows potential as a context‐specific, no‐added‐cost screening tool for ID using existing CBC data. While its diagnostic performance is modest, its scalability and accessibility could support broader public health screening efforts. Further prospective validation is recommended.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, University of California, Irvine, Orange, California, USA.
Zitieren
APA
Qiao, J., Rezk, S., & Mathur, G. (2026). Exploring low haemoglobin density as a no‐added‐cost screening marker to assess iron deficiency. Vox Sanguinis. https://doi.org/10.1111/vox.70135
Vancouver
Qiao J, Rezk S, Mathur G. Exploring low haemoglobin density as a no‐added‐cost screening marker to assess iron deficiency. Vox Sanguinis. 2026. doi:10.1111/vox.70135
BibTeX
@article{Qiao2026,
author = {Qiao, Jesse and Rezk, Sherif and Mathur, Gagan},
title = {Exploring low haemoglobin density as a no‐added‐cost screening marker to assess iron deficiency},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70135}
}
EUVIMED